Scarica l'app Stockscreener
1.53
2.55%
-0.04
Dopo l'orario di chiusura:
1.53
Precedente Chiudi:
$1.57
Aprire:
$1.57
Volume 24 ore:
912.47K
Relative Volume:
1.15
Capitalizzazione di mercato:
$196.87M
Reddito:
$514.70M
Utile/perdita netta:
$2.72M
Rapporto P/E:
-9.6287
EPS:
-0.1589
Flusso di cassa netto:
$17.08M
1 W Prestazione:
-6.71%
1M Prestazione:
-17.74%
6M Prestazione:
-43.54%
1 anno Prestazione:
-68.52%
Intervallo 1D:
$1.49
$1.57
Intervallo di 1 settimana:
$1.49
$1.73
Portata 52W:
$1.49
$7.0771
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Nome
Organogenesis Holdings Inc
Settore
Telefono
781-575-0775
Indirizzo
85 DAN ROAD, CANTON, MA
Compare ORGO vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
1.53 | 202.02M | 514.70M | 2.72M | 17.08M | -0.1589 |
TAK
Takeda Pharmaceutical Co Adr
|
18.11 | 58.15B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.35 | 42.94B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.22 | 40.59B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
72.86 | 30.29B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
503.86 | 21.74B | 3.17B | 1.29B | 1.01B | 27.09 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-28 | Iniziato | Lake Street | Buy |
| 2024-02-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-06-15 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-05-24 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-11-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-08-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-01-10 | Iniziato | SVB Leerink | Outperform |
| 2019-08-26 | Ripresa | Credit Suisse | Outperform |
| 2019-05-02 | Iniziato | Credit Suisse | Outperform |
| 2019-04-17 | Iniziato | Oppenheimer | Outperform |
| 2019-04-11 | Iniziato | SunTrust | Buy |
Mostra tutto
Organogenesis Holdings Inc Borsa (ORGO) Ultime notizie
Organogenesis stock trades without a fresh catalyst, recent results define the picture - ad-hoc-news.de
Organogenesis (ORGO) Quarter in Focus: Reported EPS Misses Expectations for the Current Session; Closing Reaction - vinanet.vn
ORGO | Organogenesis Holdings Inc. Class FinancialsRevenue Breakdown - Quiver Quantitative
Spotlighting Anixa Biosciences And 2 Other Noteworthy Penny Stocks - Sahm
Organogenesis (ORGO) Chart: Moves 3.35% Up to $1.85 on the Day; Current Setup: the Near-Term Reference Band Stretches From $1.76 to $1.94 in Latest TradingRSI Overbought Alerts - vinanet.vn
Organogenesis Holdings Inc (ORGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Organogenesis (ORGO) Q2 2026 Earnings Call Transcript - AOL.com
Oragenics: Q2 Earnings Snapshot - AOL.com
Organogenesis, lured to RI with tax credits, is bleeding money - The Business Journals
OrganiGram: Fiscal Q3 Earnings Snapshot - AOL.com
Organogenesis Holdings, Inc. Class A Revenue Breakdown – MUN:2PQ - TradingView
Organogenesis Holdings (ORGO) Holds Flat at $1.86 as Shares Consolidate Between Support and ResistanceBuffered ETF - vinanet.vn
Organogenesis Holdings (ORGO) Stock Fair Value Moves Lower After Guidance Cut And Analyst Caution - Yahoo Finance
Organogenesis Holdings Inc (ORGO) Stock News Today - TradingKey
Organogenesis Holdings (ORGO) Is Down 21.5% After Slashing 2026 Guidance And Launching Equity Offering – Has The Bull Case Changed? - Yahoo Finance
Organogenesis (NASDAQ:ORGO) Cut to Strong Sell at Wall Street Zen - MarketBeat
Organogenesis Shares Plunge After Revenue Slump, Wider Loss and Lower Outlook - Moomoo
Truist Adjusts Price Target on Organogenesis to $2 From $3, Maintains Hold Rating - marketscreener.com
Truist Financial Has Lowered Expectations for Organogenesis (NASDAQ:ORGO) Stock Price - MarketBeat
Organogenesis Holdings Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Organogenesis Q2 2026 miss sends shares lower By Investing.com - Investing.com Australia
Form 8K Organogenesis Holdings Inc For: 6 August By Investing.com - Investing.com Nigeria
Organogenesis Holdings enters at-the-market sales agreement for up to $75 million - Investing.com Nigeria
Organogenesis Holdings Inc. (ORGO) Stock Analysis: Potential 24% Upside For Investors - DirectorsTalk Interviews
Organogenesis Q2 Earnings Call Highlights - Yahoo Finance
[ORGO] Q2 2026 Earnings: Deep EPS Miss Sends Shares Down 22.8%Earnings Trend Analysis - vinanet.vn
Organogenesis earnings missed by $0.42, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Organogenesis Q2 2026 miss sends shares lower - Investing.com
Transcript : Organogenesis Holdings Inc., Q2 2026 Earnings Call, Aug 06, 2026 - marketscreener.com
Organogenesis: Q2 Earnings Snapshot - Barchart.com
Organogenesis Holdings Inc. reports results for the quarter ended June 30Earnings Summary - tradingview.com
ORGO: Q2 2026 revenue plunged 58% and net loss widened sharply amid ongoing market and regulatory challenges - TradingView
Organogenesis (Nasdaq: ORGO) sets up $75M at-the-market stock sale - Stock Titan
Organogenesis Holdings Inc. Q2 2026: Revenue $42.8M, EPS $(0.77) — 10-Q Summary - tradingview.com
Organogenesis (NASDAQ: ORGO) hit by 58% sales drop and $149M first-half loss - Stock Titan
Organogenesis Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results - The Manila Times
Organogenesis Holdings reports Q2 2026 revenue $42.8M, net loss $96.3M - TradingView
Organogenesis Holdings Inc. Revises Revenue Guidance for the Second Half of the Year Ending December 31, 2026 - marketscreener.com
Organogenesis Holdings, Inc. Class A Revenue Breakdown – LS:A2PA31 - TradingView
Organogenesis reports Q2 2026 revenue drop 58% and net loss surges to $96.3M amid slow market recovery - Pluang
ORGO Q2'26 Earnings: EPS estimate is (0.35) USD - TradingView
Organogenesis Holdings Inc. expected to post a loss of 35 cents a shareEarnings Preview - TradingView
Organogenesis Holdings (ORGO) Shows Modest Gains, Trading Near Key Support ZoneETF AUM Growth - dars.gov.et
ORGO Q1 2026 Earnings: Deep EPS Miss Signals Persistent Profitability PressuresEarnings Quality Score - vinanet.vn
Organon: Q2 Earnings Snapshot - AOL.com
Organogenesis (ORGO) to Release Quarterly Earnings on Thursday - MarketBeat
Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers - The Manila Times
Organogenesis Holdings Inc (ORGO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Organogenesis reports positive trial results for wound care product By Investing.com - Investing.com South Africa
Organogenesis reports positive trial results for wound care product - Investing.com
Organogenesis Holdings Inc Azioni (ORGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.56%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):